Relative roles of endothelial cell damage and platelet activation in primary Raynaud's phenomenon (RP) and RP secondary to systemic sclerosis

Scandinavian Journal of Rheumatology

Volumn 30, Issue 5, 2001, Pages 290-296

  Silveri, F ^a   De Angelis, R ^a   Poggi, A ^a   Muti, S ^a   Bonapace, G ^a   Argentati, F ^a   Cervini, C ^a  

^a Ospedale A Murri   (Italy)

Author keywords

Endothelial cells; Platelet release reaction; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

BETA THROMBOGLOBULIN; ENDOTHELIN 1; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; HUMAN; IMMUNOPATHOLOGY; MALE; MEASUREMENT; PATHOGENESIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE RELEASE REACTION;

ADULT; BETA-THROMBOGLOBULIN; BIOLOGICAL MARKERS; ENDOTHELIN-1; ENDOTHELIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET ACTIVATION; PLATELET-DERIVED GROWTH FACTOR; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034769920     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097401753180372     Document Type: Article

References (31)

1. Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone
2. Markers of endothelial perturbation and damage
3. Effects of peripheral cold exposure on microvascular dynamics in systemic sclerosis
4. Increased capillary permeability in systemic sclerosis: Help or hindrance?
5. Raynaud's phenomenon: A proposal for classification
6. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (Scleroderma)
7. Improved sandwich enzyme-linked immunosorbent assay for transforming growth factor beta-1
8. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo
9. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease
10. Cardiovascular responses evoked by mild cold stimuli in primary Raynaud's disease: The role of endothelin
11. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon
12. Cutaneous localization of endothelin-1 in patients with systemic sclerosis: Immunoelectron-microscopy study
13. Elevated plasma levels of endothelin-1 in systemic sclerosis
14. Significance of plasma endothelin-1 levels in patients with systemic sclerosis
15. Endothelin, an endothelial-dependent vasoconstrictor in scleroderma
16. Von Willebrand factor, thrombomodulin, thromboxane, β-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis
17. The coagulation/fibrinolysis balance in systemic sclerosis: Evidence for haematological stress syndrome
18. Hypertrophic osteoarthropathy: Endothelium and platelet function
19. Increased plasma levels of ptatetet-derived growth factor activity in patients with progressive systemic sclerosis
20. Immunoassay of platelet derived growth factor in the plasma of patients with scleroderma
21. Transforming growth factor-β in tissue fibrosis
22. Pathogenesis of scleroderma. Collagen
23. Immunohistochemical localization of intracellular and extracellular associated TGFβ in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon
24. Increased expression of TGF-β receptors by scleroderma fibroblasts: Evidence for contribution of autocrine TGF-β signaling to scleroderma phenotype
25. Plasma TGF-β in systemic sclerosis: A cross-sectional study
26. Observations on the potential role of transforming growth factor β in cutaneous fibrosis
27. Immunocytochemical localization and serological detection of TGF-β1: Association with type 1 procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphoea and Raynaud's phenomenon
28. Elevated levels of circulating ptatetet aggregates and beta-thromboglobulin in scleroderma
29. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon
30. Increased whole blood ptatelet aggregation in patients with Raynaud's phenomenon with or without systemic sclerosis
31. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis